Treatment With Ribavirin for Patients With Metastatic Breast Cancer
NCT01056757
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class
Stopped
Study closed because of new overlapping study with ribavirin.
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Ribavirin
Sponsor
Jewish General Hospital